The research on the treatment of primary immunodeficiency diseases by hematopoietic stem cell transplantation: A bibliometric analysis from 2013 to 2022

Hematopoietic stem cell transplantation (HSCT) is curative in patients with primary immunodeficiency syndrome. The safety and efficacy of HSCT as a therapeutic option for primary immunodeficiency diseases (PID) have been studied by many research groups. The purpose of our study was to perform a bibl...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Siqi, Xu, Shixia, Lu, Wei, Si, Yingjian, Wang, Ya, Du, Zhenlan, Wang, Yi, Feng, Zhichun, Tang, Xiangfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063298/
https://www.ncbi.nlm.nih.gov/pubmed/37000105
http://dx.doi.org/10.1097/MD.0000000000033295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063298/
https://www.ncbi.nlm.nih.gov/pubmed/37000105
http://dx.doi.org/10.1097/MD.0000000000033295

Ejemplares similares